ArticleBioengineering (Basel, Switzerland)2025
Performance Evaluation of a Custom-Designed Contrast Media Injector in a 5-Tesla MRI Environment.
Article in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Clinical evaluation of femoral head cartilage damage using 5-Tesla MRI T2-mapping sequence-based on pathological specimens.BMC musculoskeletal disorders · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
The compatibility and safety of contrast media injectors (CMIs) at ultra-high magnetic field strengths remains a critical challenge. This study aimed to investigate a custom-designed CMI powered by a ceramic motor in a newly developed 5T MRI environment, comparing it with a commercial CMI commonly used in a clinic. Three key performance aspects of the CMI were assessed in the 5T environment: translational attraction force, injection flow rates, and total injected volume. Potential imaging artifacts were checked. The custom-designed CMI demonstrated robust performance in the 5T environment, maintaining injection accuracy across all test locations and ensuring translational attraction forces remained within safe thresholds, even in the most challenging positions. Importantly, the custom-designed CMI exhibited no significant radiofrequency (RF) interference, and no imaging artifacts were observed across routine clinical sequences. In contrast, the commercial 3T CMI showed RF interference in several sensitive tests, such as the gradient echo (GRE) sequence with a 0° flip angle and frequency-based detection methods, underscoring the need for field-specific CMI designs tailored to ultra-high field environments. Further tests were performed in monkey livers and a human brain in vivo. The custom-designed CMI proved to be safe, accurate, and fully compatible with the 5T environment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.